Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line
Keywords
Abstract
Description
Oral squamous cell carcinoma (OSCC) is considered the most common human body malignant tumor. It has poor prognosis regarding its distant lymph node metastasis and local destruction which lead to low survival rate.
Paclitaxel is a chemotherapeutic drug of the taxols group that is used in the treatment of lung, ovarian and prostate cancer. It is also used to treat breast, head and neck cancer as well as sarcoma and leukemia. Recent studies and researches explored that Paclitaxel has an important role in mitotic arrest activation and induction, which subsequently lead to cell death.
The conventional treatment strategies such as surgery, radiotherapy and chemotherapy come with low levels of expectations regarding prognosis and survival rate. On the other hand, serious side effects of chemotherapy such as renal toxicity, gastrointestinal upset and bone marrow suppression remain hazards which cannot be avoided.Thus, there is a great need to discover new agents and strategies for treating OSCC or even enhancing the effect of chemotherapy in order to reduce the dose given.
Licorice extract, Licochalcone A, is one of many natural extracts of Glycyrrhiza inflata plant. It has been used in treatment of inflammation, infections and cancer.
Dates
Last Verified: | 08/31/2017 |
First Submitted: | 09/11/2017 |
Estimated Enrollment Submitted: | 09/21/2017 |
First Posted: | 09/25/2017 |
Last Update Submitted: | 09/21/2017 |
Last Update Posted: | 09/25/2017 |
Actual Study Start Date: | 10/31/2017 |
Estimated Primary Completion Date: | 08/31/2018 |
Estimated Study Completion Date: | 03/31/2019 |
Condition or disease
Intervention/treatment
Dietary Supplement: Licochalcone A
Drug: Paclitaxel
Phase
Arm Groups
Arm | Intervention/treatment |
---|---|
Experimental: Licochalcone A Licochalcone A is a chalconoid, a type of natural phenols. It can be isolated from root of Glycyrrhiza glabra (liquorice) or Glycyrrhiza inflata. It shows antimalarial, anticancer, antibacterial and antiviral (specifically against influenza neuraminidase) properties. | Dietary Supplement: Licochalcone A Licochalcone A is a chalconoid, a type of natural phenols. It can be isolated from root of Glycyrrhiza glabra (liquorice) or Glycyrrhiza inflata. It shows antimalarial, anticancer, antibacterial and antiviral (specifically against influenza neuraminidase) properties in vitro. |
Active Comparator: Paclitaxel chemotherapeutic drug | Drug: Paclitaxel chemotherapeutic drug |
Eligibility Criteria
Sexes Eligible for Study | All |
Accepts Healthy Volunteers | Yes |
Criteria | Inclusion Criteria: 1. All head and neck squamous cell carcinoma cell lines 2. Licochalcone extracts 3. Taxols group of chemotherapy Exclusion Criteria: 1. Animal experimental studies 2. Any cancer cell line other than squamous cell carcinoma cell lines. 3. Any chemotherapeutics other than Taxols group. |
Outcome
Primary Outcome Measures
1. Apoptosis [3 days]